Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bunge

77.35
+1.081.42%
Post-market: 77.350.00000.00%19:25 EDT
Volume:1.82M
Turnover:140.84M
Market Cap:10.40B
PE:9.89
High:77.80
Open:76.44
Low:76.29
Close:76.27
Loading ...

Bunge Global Maintains Its 2025 Adjusted EPS Forecast At Around $7.75, Vs $7.79 Est.; Excluding Upcoming Acquisitions And Divestitures

Benzinga
·
07 May

Bunge Q1 Adj. EPS $1.81 Beats $1.29 Estimate, Sales $11.64B Miss $13.05B Estimate

Benzinga
·
07 May

BRIEF-Bunge Q1 Adjusted EPS USD 1.81 Vs. IBES Estimate USD 1.29

Reuters
·
07 May

Bunge: Benefited in Q1 From Tariff-Related Timing Shifts in Demand and Farmer Activity

THOMSON REUTERS
·
07 May

Bunge: in Final Stage of Regulatory Process for Viterra Transaction

THOMSON REUTERS
·
07 May

Bunge Outlook FY Capex USD 1,500-1,700 Million

THOMSON REUTERS
·
07 May

Bunge Q1 Adjusted EPS USD 1.81 VS. Ibes Estimate USD 1.29

THOMSON REUTERS
·
07 May

Bunge Q1 EPS USD 1.48

THOMSON REUTERS
·
07 May

How To Earn $500 A Month From Bunge Global Stock Ahead Of Q1 Earnings

Benzinga
·
06 May

Bunge Global S.A. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
06 May

Bunge Gears Up to Report Q1 Earnings: What's in Store for the Stock?

Zacks
·
05 May

Top Midday Stories: Stocks Rise on Better-Than-Expected Jobs Report; Apple Forecasts $900 Million Tariff Hit in Fiscal Q3

MT Newswires Live
·
02 May

Bunge Says in Final Stage of Regulatory Approval for Viterra Merger; Earlier Bloomberg Reported US-China Trade Tensions Stalling the Deal

THOMSON REUTERS
·
02 May

Bunge's $34 billion Viterra merger stalled by US-China trade rift, Bloomberg reports

Reuters
·
02 May

Bunge's merger with Viterra stalled by US-China trade tensions, Bloomberg says

Reuters
·
02 May

BRIEF-US-China Tensions Stall Bunge'S $8.2 Billion Viterra Deal-Bloomberg News

Reuters
·
02 May

US-China Tensions Stall Bunge’s $8.2 Billion Viterra Deal-Bloomberg News

THOMSON REUTERS
·
02 May

Market Chatter: Bunge-Viterra Deal Said to be Stalled by US-China Tensions

MT Newswires Live
·
02 May

Bunge-Viterra Deal Said to be Stalled by US-China Tensions, Bloomberg Reports

MT Newswires Live
·
02 May

ReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium

GlobeNewswire
·
02 May